U.S. Markets closed

Biocept, Inc. (BIOC)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
1.41+0.01 (+0.71%)
At close: 3:59PM EDT

1.42 0.02 (1.43%)
After hours: 7:24PM EDT

People also watch
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue3,223.096609.909133.415
Cost of Revenue6,920.1114,596.1582,170.548
Gross Profit-3,697.015-3,986.249-2,037.133
Operating Expenses
Research Development2,713.3672,857.774,497.79
Selling General and Administrative11,614.6559,566.7847,339.001
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-18,025.037-16,410.803-13,873.924
Income from Continuing Operations
Total Other Income/Expenses Net153.648102.432-200.936
Earnings Before Interest and Taxes-17,871.389-16,308.371-14,074.86
Interest Expense525.88639.5471,789.68
Income Before Tax-18,397.269-16,947.918-15,864.54
Income Tax Expense2.0531.6081.506
Minority Interest---
Net Income From Continuing Ops-18,399.322-16,949.526-15,866.046
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-18,399.322-16,949.526-15,866.046
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-18,399.322-16,949.526-15,866.046